Medicaid PARTNERSHIP Act
The source supplies the latest action, but no lifecycle stage.
Latest action (20 Jun 2018): Received in the Senate and Read twice and referred to the Committee on Finance.
What this bill does
This bill, H.R. 5801, called the Medicaid PARTNERSHIP Act, would require states to establish prescription drug monitoring programs (PDMPs). Healthcare providers participating in Medicaid would need to check these PDMPs for a patient's controlled substance prescription history before prescribing them. The PDMPs must provide details on the number and type of controlled substances prescribed to a Medicaid enrollee over the past 12 months. The bill also includes provisions to temporarily increase federal funding for states that enhance PDMP interoperability with neighboring states.
The Centers for Medicare & Medicaid Services would be tasked with providing guidance and best practices to states on PDMP usage. Additionally, the Government Accountability Office would report on how these programs are managed. The bill defines "controlled substance" and outlines exceptions for certain patient populations or situations, such as emergency services.
H.R. 5801 has passed the House of Representatives and will now move to the Senate for consideration. If it passes the Senate, it would then go to the President to be signed into law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients Act or the Medicaid PARTNERSHIP Act
(Sec. 2) This bill requires each state to: (1) establish a prescription drug monitoring program (PDMP), and (2) require health care providers to check the PDMP for a Medicaid enrollee's prescription drug history before prescribing controlled substances to the enrollee. In addition to meeting other specified requirements, each PDMP must allow health care providers to access the number and type of controlled substances prescribed to a Medicaid enrollee during the most recent 12-month period.
The bill also temporarily increases the federal matching rate with respect to Medicaid expenditures related to PDMP implementation for states that have agreements to promote PDMP interoperability with their neighboring states.
The Centers for Medicare & Medicaid Services must publish guidance and best practices for states regarding PDMP utilization. Additionally, the Government Accountability Office must report on PDMP administration.
Timeline
20 Jun 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Common questions
- What does H.R. 5801 do?
- This bill, H.R. 5801, called the Medicaid PARTNERSHIP Act, would require states to establish prescription drug monitoring programs (PDMPs). Healthcare providers participating in Medicaid would need to check these PDMPs for a patient's controlled substance prescription history before prescribing them. The PDMPs must provide details on the number and type of controlled substances prescribed to a Medicaid enrollee over the past 12 months. The bill also includes provisions to temporarily increase federal funding for states that enhance PDMP interoperability with neighboring states. The Centers for Medicare & Medicaid Services would be tasked with providing guidance and best practices to states on PDMP usage. Additionally, the Government Accountability Office would report on how these programs are managed. The bill defines "controlled substance" and outlines exceptions for certain patient populations or situations, such as emergency services. H.R. 5801 has passed the House of Representatives and will now move to the Senate for consideration. If it passes the Senate, it would then go to the President to be signed into law.
- Has H.R. 5801 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 5801. Check the latest action and official source below.
- Who sponsored H.R. 5801?
- H.R. 5801 was sponsored by Rep. Griffith, H. Morgan [R-VA-9] (R-VA), with 3 cosponsors.
- What's the latest action on H.R. 5801?
- Received in the Senate and Read twice and referred to the Committee on Finance. (20 Jun 2018).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Lower Premiums, Faster Payments Act
Access to Medical Supplies Act
More bills from Rep. Griffith, H. Morgan [R-VA-9]
Medicaid Fraud Fighting and Taxpayer Protection Act
Legislative Branch Agencies Clarification Act
CONNECTIONS Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.